From diagnostics to CRISPR and policy reform, explore how science and society are working together to combat the rising threat of antibiotic resistance.

Paul Thomas Anderson’s action epic “One Battle After Another” swept the National Board of Review‘s 2025 awards, claiming best film, director, actor for Leonardo DiCaprio, supporting actor for Benicio ...

Paul Thomas Anderson's latest picks up some big wins from NBR, including Best Film, Best Director, Best Actor for Leonardo DiCaprio, Best Supporting Actor for Benicio Del Toro, and Breakthrough ...

Paul Thomas Anderson’s One Battle After Another continued its roll through the early awards season gauntlet Wednesday, when it was selected the Best Film by the National Board of Review. The group of ...

Anthony Taormina is an original member of the GameRant team, having been part of the publication for 15 years. He coordinates content for all facets of the site and manages its social media, PR, and ...

CARROLL GARDENS — The city’s final environmental scoping hearing on the $3.5 billion redevelopment of the Brooklyn Marine Terminal takes place Monday, Dec. 1, and locals are cramming in lessons on how ...

The iPhone 17 does everything that’s asked of it to an exceptionally high standard. The design is smart and robust; the screen is big and bright and equipped with pro features; the camera takes great ...

A comprehensive review and tutorial of the Moomoo app. Learn about commission-free stock trading, advanced charting, and research tools. Invest with confidence! Theft of Guy Fieri's tequila sheds ...

My passion for looter shooters has burned quite brightly for over 15 years and Borderlands is the flame that lit the fuse. With Borderlands 4, Gearbox proves it still knows how to bring the boom.

Among the many movie traditions (i.e., clichés) running amok in “My Oxford Year” is an incurable and only vaguely defined illness, one that affects a principal character and basically drives the plot.

Joshua Winowiecki does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...